About SINGLETTO INC.
Singletto develops Oxafence Active Protection™, a materials-applied antimicrobial technology platform designed for integration into existing products, with FDA-cleared applications in face masks. The technology enables ongoing antimicrobial performance in materials used in healthcare, military, and shared environments.
Materials-applied antimicrobial technology integrationActive, ongoing antimicrobial performance in materialsFDA-cleared face masks with virus inactivation capabilitiesIntegration into existing manufacturing processesApplication across multiple environments including healthcare, military, and shared public spaces
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| DARPA EMBEDDED ENTREPRENEURSHIP INITIATIVE (EEI) | Department of Defense | $310K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to SINGLETTO INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.